Chan M, Preston EV, Fruh V, Quinn MR, Hacker MR, Wylie BJ, O'Brien K, Williams PL, Hauser R, James-Todd T, and Mahalingaiah S. 5/2023. “Use of personal care products during pregnancy and birth outcomes - A pilot study.” Environ Res, 225.

James-Todd T, Ponzano M, Bellavia A, Williams PL, Cantonwine DE, Calafat AM, Hauser R, Quinn MR, Seely EW, and McElrath TF. 3/2022. “Urinary phthalate and DINCH metabolite concentrations and gradations of maternal glucose intolerance.” Environ Int, 161.

Barett ES, Groth SW, Preston EV, Kinkade C, and James-Todd T. 9/2021. “Endocrine-Disrupting Chemical Exposures in Pregnancy: a Sensitive Window for Later-Life Cardiometabolic Health in Women.” Curr Epidemiol Rep, 8, 3.

Preston EV, Fruh V, Quinn MR, Hacker MR, Wylie BJ, O'Brien K, Mahalingaiah S, and James-Todd T. 7/2021. “Endocrine disrupting chemical-associated hair product use during pregnancy and gestational age at delivery: a pilot study.” Environ Health, 20, 1.

Wang VA, James-Todd T, Hacker MR, O'Brien KE, Wylie BJ, Hauser R, Williams PL, Bellavia A, Quinn M, McElrath TF, and Papatheodorou S. 6/2021. “Ambient PM gross β-activity and glucose levels during pregnancy.” Environ Health, 20, 1.

James-Todd T, Connolly L, Preston EV, Quinn MR, Plotan M, Xie Y, Gandi B, and Mahalingaiah S. 5/2021. “Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities.” J Expo Sci Environ Epidemiol, 31, 3.

Preston EV, Chan M, Nozhenko K, Bellavia A, Grenon MC, Cantonwine DE, McElrath TF, and James-Todd T. 2021. “Socioeconomic and racial/ethnic differences in use of endocrine-disrupting chemical-associated personal care product categories among pregnant women.” Environ Res, 198.

Preston EV, Rifas-Shiman SL, Hivert MF, Zota AR, Sagiv SK, Calafat AM, Oken E, and James-Todd T. 8/1/2020. “Associations of Per- and Polyfluoroalkyl Substances (PFAS) With Glucose Tolerance During Pregnancy in Project Viva.” J Clin Endocrinol Metab, 105, 8.

Fruh V, Preston EV, Quinn MR, Hacker MR, Wylie BJ, O'Brien K, Hauser R, James-Todd T, and Mahalingaiah S. 8/2020. “Urinary phthalate metabolite concentrations and personal care product use during pregnancy - Results of a pilot study.” Sci Total Environ, 835.

Zheng Y, Zhang C, Weisskopf MG, Williams PL, Claus Henn B, Parsons PJ, Palmer CD, Buck Louis GM, and James-Todd T. 3/2020. “Evaluating associations between early pregnancy trace elements mixture and 2nd trimester gestational glucose levels: A comparison of three statistical approaches.” Int J Hyg Environ Health, 224.

Bellavia A, Mínguez-Alarcón L, Ford JB, Keller M, Petrozza J, Williams PL, Hauser R, and James-Todd T. 12/10/2019. “Association of self-reported personal care product use with blood glucose levels measured during pregnancy among women from a fertility clinic.” Sci Total Environ, 695.

Zheng Y, Zhang C, Weisskopf M, Williams PL, Parsons PJ, Palmer CD, Buck Louis GM, and James-Todd T. 10/1/2019. “A Prospective Study of Early Pregnancy Essential Metal(loid)s and Glucose Levels Late in the Second Trimester.” J Clin Endocrinol Metab, 104, 10, Pp. 4295-4303.

Noor N, Ferguson KK, Meeker JD, Seely EW, Hauser R, James-Todd T, and McElrath TF. 4/2019. “Pregnancy phthalate metabolite concentrations and infant birth weight by gradations of maternal glucose tolerance.” Int J Hyg Environ Health, 222, 3, Pp. 395-401.

Shaffer RM, Ferguson KK, Sheppard L, James-Todd T, Butts S, Chandrasekaran S, Swan SH, Barrett ES, Nguyen R, Bush N, McElrath TF, and Sathyanarayana S. 2/2019. “Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during pregnancy.” Environ Int, 123, Pp. 588-596.

Stuart JJ, Tanz LJ, Missmer SA, Rimm EB, Spiegelman D, James-Todd TM, and Rich-Edwards JW. 8/21/2018. “Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study.” Ann Intern Med, 169, 4, Pp. 224-232.

James-Todd TM, Chiu YH, Messerlian C, Mínguez-Alarcón L, Ford JB, Keller M, Petrozza J, Williams PL, Ye X, Calafat AM, and Hauser R. 6/14/2018. “Trimester-specific phthalate concentrations and glucose levels among women from a fertility clinic.” Environmental health : a global access science source, 17, 1, Pp. 55.

Mitro SD, Chu MT, Dodson RE, Adamkiewicz G, Chie L, Brown FM, and James-Todd TM. 3/23/2018. “Phthalate metabolite exposures among immigrants living in the United States: findings from NHANES, 1999-2014.” Journal of exposure science & environmental epidemiology.

James-Todd T, March MI, Seiglie J, Gupta M, Brown M, and Majzoub JA. 12/5/2017. “Racial differences in neonatal hypoglycemia among very early preterm births .” J Perinatol.

Bellavia A, Hauser R, Seely EW, Meeker JD, Ferguson KK, McElrath TF, and James-Todd T. 11/2017. “Urinary phthalate metabolite concentrations and maternal weight during early pregnancy.” Int J Hyg Environ Health, 220, 8, Pp. 1347-1355.

Chiu YH, Mínguez-Alarcón L, Ford JB, Keller M, Seely EW, Messerlian C, Petrozza J, Williams PL, Ye X, Calafat AM, Hauser R, and James-Todd TM. 4/1/2017. “Trimester-specific urinary bisphenol A concentrations and blood glucose levels among women from a fertility clinic .” JCEM, 102, 4, Pp. 1305-1357.